Cementos Bio Valuation
| CEMENTOS | CLP 1,400 100.00 7.69% |
At this time, the firm appears to be fairly valued. Cementos Bio B shows a prevailing Real Value of 1345.16 per share. The current price of the firm is 1400.0. Our model approximates the value of Cementos Bio B from analyzing the firm fundamentals such as Profit Margin of 0.05 %, current valuation of 293.1 B, and Return On Equity of 0.0705 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Cementos Bio's price fluctuation is very steady at this time. Calculation of the real value of Cementos Bio B is based on 3 months time horizon. Increasing Cementos Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Cementos Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cementos Stock. However, Cementos Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1400.0 | Real 1345.16 | Hype 1300.0 | Naive 1609.65 |
The intrinsic value of Cementos Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cementos Bio's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Cementos Bio B helps investors to forecast how Cementos stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cementos Bio more accurately as focusing exclusively on Cementos Bio's fundamentals will not take into account other important factors: Cementos Bio Total Value Analysis
Cementos Bio B is currently estimated to have takeover price of 293.1 B with market capitalization of 171.37 B, debt of 97.47 B, and cash on hands of 31.62 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Cementos Bio fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
293.1 B | 171.37 B | 97.47 B | 31.62 B |
Cementos Bio Investor Information
About 82.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.71. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cementos Bio B recorded earning per share (EPS) of 65.73. The entity last dividend was issued on the 30th of March 2022. Based on the analysis of Cementos Bio's profitability, liquidity, and operating efficiency, Cementos Bio B is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Cementos Bio Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Cementos suggests not a very effective usage of assets in November.Cementos Bio Ownership Allocation
Cementos Bio holds a total of 264.22 Million outstanding shares. Cementos Bio B shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 82.46 percent of Cementos Bio B outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Cementos Bio Profitability Analysis
The company reported the revenue of 289.47 B. Net Income was 26.88 B with profit before overhead, payroll, taxes, and interest of 103.18 B.About Cementos Bio Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Cementos Bio B. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Cementos Bio B based exclusively on its fundamental and basic technical indicators. By analyzing Cementos Bio's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Cementos Bio's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cementos Bio. We calculate exposure to Cementos Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cementos Bio's related companies.Cementos Bio Bio S.A. manufactures and sells cement in Chile and internationally. The company was founded in 1957 and is based in Providencia, Chile. CEMENTOS BIO is traded on Commodity Exchange in Exotistan.
8 Steps to conduct Cementos Bio's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Cementos Bio's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Cementos Bio's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Cementos Bio's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Cementos Bio's revenue streams: Identify Cementos Bio's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Cementos Bio's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Cementos Bio's growth potential: Evaluate Cementos Bio's management, business model, and growth potential.
- Determine Cementos Bio's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Cementos Bio's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Cementos Stock
Cementos Bio financial ratios help investors to determine whether Cementos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cementos with respect to the benefits of owning Cementos Bio security.